Published in Nature on April 14, 1987
The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni. EMBO J (1988) 1.55
Drosophila glutathione S-transferase 1-1 shares a region of sequence homology with the maize glutathione S-transferase III. Proc Natl Acad Sci U S A (1990) 1.30
The human liver glutathione S-transferase gene superfamily: expression and chromosome mapping of an Hb subunit cDNA. Nucleic Acids Res (1988) 1.27
Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc Natl Acad Sci U S A (1994) 1.16
Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl Trop Dis (2012) 1.08
Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation. J Exp Med (1993) 1.07
Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis. Proc Natl Acad Sci U S A (1996) 0.99
Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides. J Clin Microbiol (1990) 0.97
Gender-dependent specific immune response during chronic human Schistosomiasis haematobia. Clin Exp Immunol (2001) 0.97
Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin. J Clin Invest (1989) 0.94
Relationship of impairment of schistosome 28-kilodalton glutathione S-transferase (GST) activity to expression of immunity to Schistosoma mattheei in calves vaccinated with recombinant Schistosoma bovis 28-kilodalton GST. Infect Immun (1998) 0.93
Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies. Parasitol Res (2010) 0.91
A novel type of glutathione S-transferase in Onchocerca volvulus. Infect Immun (1994) 0.91
Novel therapeutic and prevention approaches for schistosomiasis: review. J Adv Res (2012) 0.89
Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection. BMC Immunol (2010) 0.88
Molecular cloning of an immunodominant antigen of Onchocerca volvulus. J Exp Med (1988) 0.86
Immune response to Schistosoma mansoni phosphoglycerate kinase during natural and experimental infection: identification of a schistosome-specific B-cell epitope. Infect Immun (1995) 0.85
High levels of protection induced by a 40-mer synthetic peptide vaccine against the intestinal nematode parasite Trichinella spiralis. Immunology (1995) 0.83
The redox biology of schistosome parasites and applications for drug development. Curr Pharm Des (2012) 0.83
Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen. Infect Immun (1999) 0.82
The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils. Mucosal Immunol (2015) 0.78
Schistosoma mansoni antigens differentially recognized by resistant WEHI 129/J mice. Infect Immun (1988) 0.78
Immunogenicity of genetically engineered glutathione S-transferase fusion proteins containing a T-cell epitope from diphtheria toxin. Infect Immun (1995) 0.77
Molecular cloning and enzymatic characterization of a class mu glutathione S-transferase of Paragonimus westermani. Parasitol Res (2007) 0.77
Expression of a Schistosoma mansoni 28-kilodalton glutathione S-transferase in the livers of transgenic mice and its effect on parasite infection. Infect Immun (1997) 0.76
Infection with Salmonella typhimurium modulates the immune response to Schistosoma mansoni glutathione-S-transferase. Infect Immun (1997) 0.75
Helminth Immunomodulation in Autoimmune Disease. Front Immunol (2017) 0.75
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85
Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature (1992) 5.45
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (1987) 5.45
Chromogenic identification of genetic regulatory signals in Bacillus subtilis based on expression of a cloned Pseudomonas gene. Proc Natl Acad Sci U S A (1983) 5.33
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med (1992) 5.29
Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20
Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med (1991) 5.04
New versatile cloning and sequencing vectors based on bacteriophage M13. Gene (1983) 4.55
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today (1991) 3.79
Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (1984) 3.32
Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases. Br Med J (1977) 3.10
Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A (1984) 2.85
Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol (2002) 2.79
[Immunoenzymologic diagnosis of parasitic diseases. II. Quantitative immunoenzymology]. Lille Med (1976) 2.74
cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett (1991) 2.70
Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature (1992) 2.67
Linker tailing: unphosphorylated linker oligonucleotides for joining DNA termini. DNA (1984) 2.56
Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucleic Acids Res (1983) 2.56
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol (1992) 2.33
Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus). Proc Natl Acad Sci U S A (1984) 2.23
Estimation of lung volumes from chest radiographs using shape information. Thorax (1979) 2.23
Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules. Nature (1975) 2.19
Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax (2009) 2.18
Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol (1983) 2.17
A new function for platelets: IgE-dependent killing of schistosomes. Nature (1983) 2.11
Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest (1984) 2.07
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Cell-free synthesis of enterotoxin of E. coli from a cloned gene. Nature (1980) 2.02
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01
Transient induction of a peroxidase gene in Medicago truncatula precedes infection by Rhizobium meliloti. Plant Cell (1995) 1.98
High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature (1994) 1.95
Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci U S A (1997) 1.94
Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J (1993) 1.90
Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell (1992) 1.81
Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med (2001) 1.79
Molecular crosstalk in host-parasite relationships: schistosome- and leech-host interactions. Parasitol Today (2000) 1.73
Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci U S A (1989) 1.73
Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology (1996) 1.73
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol (1991) 1.72
IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet (1988) 1.70
The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin. J Biol Chem (1991) 1.70
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.65
Serodiagnosis of toxoplasma infection using a purified parasite protein (P30). Clin Exp Immunol (1985) 1.64
Fc receptors for IgE on human and rat eosinophils. J Immunol (1981) 1.63
Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci U S A (1992) 1.62
Evidence for IgE-dependent cytotoxicity by rat eosinophils. J Immunol (1981) 1.61
AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy (2008) 1.59
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg (1985) 1.58
The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni. EMBO J (1988) 1.55
Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res (1991) 1.52
Immunity to schistosomes: progress toward vaccine. Science (1987) 1.49
Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with the NF-kappaB pathway. Eur J Immunol (1999) 1.49
Methods of studying lobar and segmental function of the lung in man. Br J Dis Chest (1979) 1.49
Interaction between IgE complexes and macrophages in the rat: a new mechanism of macrophage activation. Eur J Immunol (1977) 1.48
Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol (1995) 1.48
Quantitative determination of specific IgE antibodies to Echinococcus granulosus and IgE levels in sera from patients with hydatid disease. Immunology (1975) 1.47
Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol (1991) 1.46
In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol (1998) 1.45
Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature (1986) 1.45
[Antigenic structure of helminthes. Immunological aspects of the host-parasite relationship]. Pathol Biol (1968) 1.45
The structural gene for the ribosomal protein S18 in Escherichia coli. I. Genetic studies on a mutant having an alteration in the protein S18. J Mol Biol (1973) 1.44
Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis. Nature (1985) 1.44
Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest (1983) 1.44
Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proc Natl Acad Sci U S A (1988) 1.43
Radiographic, scintigraphic, and gas-dilution estimates of individual lung and lobar volumes in man. Thorax (1980) 1.42
Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clin Exp Immunol (1980) 1.42
Receptor for IgG(Fc) and human beta2-microglobulin on S. mansoni schistosomula. Nature (1979) 1.41
Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J (1991) 1.40
An evaluation of the Breath-Taker peak flow meter. Med J Aust (1990) 1.40
Silica gel: an improved support for the solid-phase phosphotriester synthesis of oligonucleotides. Nucleic Acids Res (1982) 1.40
Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol (2005) 1.40
A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol (1987) 1.39
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol (1989) 1.39
[Eosinophils and pathology of the digestive tract]. Gastroenterol Clin Biol (1990) 1.38